File:Drew_Weissman,_2023_Nobel_Laureate_in_Medicine_(cropped).jpg · Wikimedia Commons · See Wikimedia Commons
Drew Weissman
Sign in to saveAmerican physician-scientist (born 1959)
OverviewAI-generated
Drew Weissman is an American researcher, biochemist, university teacher, and inventor. Born in Lexington in 1959, he holds United States citizenship and practices Judaism. He was educated at Brandeis University and Boston University. His professional work focuses on messenger RNA and RNA vaccines, with an interest in molecular biology. He is employed by the Perelman School of Medicine at the University of Pennsylvania and the University of Pennsylvania.
Weissman has received several honors, including the Princess of Asturias Award for Technical and Scientific Research, the Breakthrough Prize in Life Sciences, and the Rosenstiel Award. He is a member and Fellow of the American Academy of Arts and Sciences. Additionally, he is recognized in the National Inventors Hall of Fame collection and the Nobel Medicine collection.
Synthesized by Vinony from 27 facts across 6 sources: Wikidata, Crossref, MusicBrainz, Nobel Prize, Vinony collections, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Music · MusicBrainz
- Type
- Person
- Gender
- Male
- Origin
- United States
- Active from
- 1916-03-22
- Active to
- 2003-05-22
via MusicBrainz · CC0
Recent publications · Crossref
5 total works indexed
- The blockade of immune checkpoints in cancer immunotherapy
· 2012 · cited 11,961x
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
· 2012 · cited 10,836x
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
· 2012 · cited 9,265x
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
· 2015 · cited 8,241x
- Stem cells, cancer, and cancer stem cells
· 2001 · cited 7,605x
via Crossref · CC0
Key facts
- Born
- ( 1959-09-07 ) September 7, 1959 (age 66) , Lexington, Massachusetts , U.S.
- Education
- Brandeis University ( BA , MA ) Boston University ( MD , PhD )
- Known for
- Modified mRNA technologies used in COVID-19 vaccines
- Awards
- Rosenstiel Award (2020) Lasker–DeBakey Clinical Medical Research Award (2021) VinFuture Prize (2022) Breakthrough Prize in Life Sciences (2022) Harvey Prize (2023) Nobel Prize in Physiology or Medicine (2023)
- Fields
- Immunology
- Institutions
- University of Pennsylvania
- Thesis
- Regulation of b lymphocytes with reagents that cross-link surface immunoglobulin (1987)
- Doctoral advisor
- Ann Marshak-Rothstein
via Wikipedia infobox
Nobel Prize
- The Nobel Prize in Physiology or Medicine2023
“for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
Shared · 1/2 portion
~7 min read
Encyclopedic overview
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With biochemist Katalin Karikó, Weissman received the Nobel Prize in Physiology or Medicine in 2023 "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19". Weissman has been a recipient and co-recipient of numerous awards, also including the prestigious Lasker–DeBakey Clinical Medical Research Award. In 2022, he was elected to the National Academy of Medicine and the American Academy of Arts and Sciences.
Excerpted from Wikipedia’s “Drew Weissman” article, available under the CC BY-SA 4.0 licence.